Science & Technology
Wed, March 28, 2012 
WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Comverge, Inc. (aComvergea or athe Companya) (Nasdaq: COMV), concerning the proposed acquisition of the Company by H.I.G. Capital. Under the terms of the transaction, Comverge shareholders would receive $1.75 per share in a deal valued at approximately $49 million.
The deal offers no premium to Comvergeas shareholders. Indeed, the offer is below market price, falling $0.13 under Comvergeas March 23 close of $1.88. At least six analysts have set target prices averaging $3.23, with one analyst setting a target as high as $8.65.
The investigation focuses on the potential unfairness of the consideration to Comvergeas shareholders, the process by which the Companyas Board of Directors considered the transaction, and potential conflicts of interests among Comvergeas Board members.
If you are interested in discussing your rights as a Comverge shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, D.C. offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our website at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.
